Search Results : HIV

604 interactions found:

Novel Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
calmegin
Name2
ADAM metallopeptidase domain 2
Pathway 1
Pathway 2
  • Interaction With Cumulus Cells And The Zona Pellucida
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
interleukin 12A
Name2
interleukin 12B
Pathway 1
  • Interleukin-10 signaling
  • Interleukin-4 and Interleukin-13 signaling
  • Interleukin-35 Signalling
  • Interleukin-12 signaling
  • Interleukin-12 signaling
Pathway 2
  • Interleukin-10 signaling
  • Interleukin-4 and Interleukin-13 signaling
  • Interleukin-12 signaling
  • Interleukin-12 signaling
  • Interleukin-23 signaling
  • Interleukin-23 signaling
Drugs 1
Drugs 2
  • 5-Mercapto-2-Nitro-Benzoic Acid
  • Briakinumab
  • Ustekinumab
  • Ustekinumab
  • humanized SMART Anti-IL-12 Antibody
  • Tildrakizumab
  • Risankizumab
Diseases 1
Diseases 2
  • IFN-gamma/IL-12 axis, including the following five diseases: IL-12 p40 subunit deficiency; IL-12 receptor (IL-12R) beta1 chain deficiency; IFN-gamma receptor (IFN gamma R) alpha chain deficiency; IFN-gamma receptor (IFN gamma R) beta chain deficiency; STAT-1 deficiency
Novel
Novel
Symbols
Name 1
adenylate cyclase 2
Name2
adenylate cyclase 5
Pathway 1
  • Glucagon signaling in metabolic regulation
  • PKA activation
  • PKA activation in glucagon signalling
  • Adenylate cyclase activating pathway
  • Adenylate cyclase inhibitory pathway
  • Adenylate cyclase inhibitory pathway
  • G alpha (s) signalling events
  • G alpha (s) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
  • G alpha (z) signalling events
  • Vasopressin regulates renal water homeostasis via Aquaporins
  • Hedgehog 'off' state
  • GPER1 signaling
  • GPER1 signaling
  • ADORA2B mediated anti-inflammatory cytokines production
  • ADORA2B mediated anti-inflammatory cytokines production
  • FCGR3A-mediated IL10 synthesis
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
Pathway 2
  • Glucagon signaling in metabolic regulation
  • PKA activation
  • PKA activation in glucagon signalling
  • Adenylate cyclase activating pathway
  • Adenylate cyclase inhibitory pathway
  • Adenylate cyclase inhibitory pathway
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • Adrenaline,noradrenaline inhibits insulin secretion
  • G alpha (s) signalling events
  • G alpha (s) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
  • G alpha (z) signalling events
  • Vasopressin regulates renal water homeostasis via Aquaporins
  • Hedgehog 'off' state
  • GPER1 signaling
  • GPER1 signaling
  • ADORA2B mediated anti-inflammatory cytokines production
  • ADORA2B mediated anti-inflammatory cytokines production
  • FCGR3A-mediated IL10 synthesis
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
Drugs 1
  • Colforsin
  • Colforsin
  • 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE
  • Aurothioglucose
Drugs 2
  • Colforsin
  • Colforsin
  • 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE
  • Aurothioglucose
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
retinol binding protein 4
Name2
retinoid isomerohydrolase RPE65
Pathway 1
  • The canonical retinoid cycle in rods (twilight vision)
  • Retinoid metabolism disease events
  • Retinoid metabolism and transport
  • Defective visual phototransduction due to STRA6 loss of function
Pathway 2
  • The canonical retinoid cycle in rods (twilight vision)
Drugs 1
  • Tretinoin
Drugs 2
  • Voretigene neparvovec
Diseases 1
Diseases 2
  • Leber congenital amaurosis (LCR)
  • Retinitis pigmentosa (RP)
Novel
Novel
Name 1
tripartite motif containing 54
Name2
long intergenic non-protein coding RNA 887
Pathway 1
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
caldesmon 1
Name2
SHC adaptor protein 1
Pathway 1
  • Smooth Muscle Contraction
Pathway 2
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • SHC1 events in ERBB2 signaling
  • SHC1 events in ERBB2 signaling
  • SHC1 events in ERBB4 signaling
  • Signalling to RAS
  • Signalling to RAS
  • SHC1 events in EGFR signaling
  • Tie2 Signaling
  • Integrin signaling
  • XBP1(S) activates chaperone genes
  • Interleukin-3, Interleukin-5 and GM-CSF signaling
  • Constitutive Signaling by EGFRvIII
  • RAF/MAP kinase cascade
  • Signal attenuation
  • Insulin receptor signalling cascade
  • Insulin receptor signalling cascade
  • RET signaling
  • Interleukin-15 signaling
  • Interleukin-15 signaling
  • Interleukin-2 signaling
  • Erythropoietin activates RAS
  • Erythropoietin activates RAS
  • Interleukin receptor SHC signaling
  • Constitutive Signaling by Overexpressed ERBB2
  • Signaling by ERBB2 KD Mutants
  • Signaling by ERBB2 ECD mutants
  • Signaling by ERBB2 TMD/JMD mutants
  • Signaling by CSF3 (G-CSF)
  • Signaling by CSF3 (G-CSF)
  • Signaling by CSF1 (M-CSF) in myeloid cells
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
cytochrome b5 type A
Name2
cytochrome P450 family 3 subfamily A member 4
Pathway 1
  • Vitamin C (ascorbate) metabolism
Pathway 2
  • Phase I - Functionalization of compounds
  • Xenobiotics
  • Aflatoxin activation and detoxification
  • Biosynthesis of maresin-like SPMs
  • Aspirin ADME
  • Atorvastatin ADME
  • Prednisone ADME
Drugs 1
  • Dimethyl Propionate Ester Heme
  • Chromium
  • Chromic citrate
  • Chromic nitrate
  • Chromium gluconate
  • Chromium nicotinate
  • Chromous sulfate
Drugs 2
  • Glutathione
  • Isoniazid
  • Pradefovir mesylate
  • Casopitant
  • Cobicistat
  • Diacerein
Diseases 1
  • Methemoglobinemia
Diseases 2
Novel
Novel
Name 1
cytochrome b5 type A
Name2
UDP glucuronosyltransferase family 1 member A4
Pathway 1
  • Vitamin C (ascorbate) metabolism
Pathway 2
  • Glucuronidation
  • Heme degradation
  • Defective UGT1A4 causes hyperbilirubinemia
  • Aspirin ADME
Drugs 1
  • Dimethyl Propionate Ester Heme
  • Chromium
  • Chromic citrate
  • Chromic nitrate
  • Chromium gluconate
  • Chromium nicotinate
  • Chromous sulfate
Drugs 2
Diseases 1
  • Methemoglobinemia
Diseases 2
Novel
Novel
Name 1
transcription factor CP2
Name2
DnaJ heat shock protein family (Hsp40) member C5 beta
Pathway 1
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
BRCA1 associated protein
Name2
SHC binding and spindle associated 1 like
Pathway 1
  • RAF activation
  • Negative regulation of MAPK pathway
  • Signaling by moderate kinase activity BRAF mutants
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • Signaling downstream of RAS mutants
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
ENY2 transcription and export complex 2 subunit
Name2
ataxin 7 like 3B
Pathway 1
  • HATs acetylate histones
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
NPR3 like, GATOR1 complex subunit
Name2
sestrin 3
Pathway 1
  • Amino acids regulate mTORC1
Pathway 2
  • TP53 Regulates Metabolic Genes
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
nuclear receptor coactivator 5
Pathway 1
Pathway 2
Drugs 1
  • Polyethylene glycol 400
Drugs 2
  • 17alpha-Estriol
Diseases 1
Diseases 2
Novel
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
anti-silencing function 1A histone chaperone
Pathway 1
Pathway 2
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
SH3 domain containing GRB2 like, endophilin B1
Pathway 1
Pathway 2
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
mitochondrial elongation factor 1
Pathway 1
Pathway 2
  • Mitochondrial ribosome-associated quality control
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
abhydrolase domain containing 4, N-acyl phospholipase B
Pathway 1
Pathway 2
  • Acyl chain remodelling of PE
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
junctophilin 1
Pathway 1
Pathway 2
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
mitochondrial translational initiation factor 3
Pathway 1
Pathway 2
  • Mitochondrial translation initiation
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
family with sequence similarity 209 member A
Pathway 1
Pathway 2
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
calmegin
Name2
ADAM metallopeptidase domain 2
Pathway 1
Pathway 2
  • Interaction With Cumulus Cells And The Zona Pellucida
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
interleukin 12A
Name2
interleukin 12B
Pathway 1
  • Interleukin-10 signaling
  • Interleukin-4 and Interleukin-13 signaling
  • Interleukin-35 Signalling
  • Interleukin-12 signaling
  • Interleukin-12 signaling
Pathway 2
  • Interleukin-10 signaling
  • Interleukin-4 and Interleukin-13 signaling
  • Interleukin-12 signaling
  • Interleukin-12 signaling
  • Interleukin-23 signaling
  • Interleukin-23 signaling
Drugs 1
Drugs 2
  • 5-Mercapto-2-Nitro-Benzoic Acid
  • Briakinumab
  • Ustekinumab
  • Ustekinumab
  • humanized SMART Anti-IL-12 Antibody
  • Tildrakizumab
  • Risankizumab
Diseases 1
Diseases 2
  • IFN-gamma/IL-12 axis, including the following five diseases: IL-12 p40 subunit deficiency; IL-12 receptor (IL-12R) beta1 chain deficiency; IFN-gamma receptor (IFN gamma R) alpha chain deficiency; IFN-gamma receptor (IFN gamma R) beta chain deficiency; STAT-1 deficiency
Novel
Symbols
Name 1
adenylate cyclase 2
Name2
adenylate cyclase 5
Pathway 1
  • Glucagon signaling in metabolic regulation
  • PKA activation
  • PKA activation in glucagon signalling
  • Adenylate cyclase activating pathway
  • Adenylate cyclase inhibitory pathway
  • Adenylate cyclase inhibitory pathway
  • G alpha (s) signalling events
  • G alpha (s) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
  • G alpha (z) signalling events
  • Vasopressin regulates renal water homeostasis via Aquaporins
  • Hedgehog 'off' state
  • GPER1 signaling
  • GPER1 signaling
  • ADORA2B mediated anti-inflammatory cytokines production
  • ADORA2B mediated anti-inflammatory cytokines production
  • FCGR3A-mediated IL10 synthesis
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
Pathway 2
  • Glucagon signaling in metabolic regulation
  • PKA activation
  • PKA activation in glucagon signalling
  • Adenylate cyclase activating pathway
  • Adenylate cyclase inhibitory pathway
  • Adenylate cyclase inhibitory pathway
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • Adrenaline,noradrenaline inhibits insulin secretion
  • G alpha (s) signalling events
  • G alpha (s) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
  • G alpha (z) signalling events
  • Vasopressin regulates renal water homeostasis via Aquaporins
  • Hedgehog 'off' state
  • GPER1 signaling
  • GPER1 signaling
  • ADORA2B mediated anti-inflammatory cytokines production
  • ADORA2B mediated anti-inflammatory cytokines production
  • FCGR3A-mediated IL10 synthesis
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
Drugs 1
  • Colforsin
  • Colforsin
  • 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE
  • Aurothioglucose
Drugs 2
  • Colforsin
  • Colforsin
  • 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE
  • Aurothioglucose
Diseases 1
Diseases 2
Novel
Symbols
Name 1
retinol binding protein 4
Name2
retinoid isomerohydrolase RPE65
Pathway 1
  • The canonical retinoid cycle in rods (twilight vision)
  • Retinoid metabolism disease events
  • Retinoid metabolism and transport
  • Defective visual phototransduction due to STRA6 loss of function
Pathway 2
  • The canonical retinoid cycle in rods (twilight vision)
Drugs 1
  • Tretinoin
Drugs 2
  • Voretigene neparvovec
Diseases 1
Diseases 2
  • Leber congenital amaurosis (LCR)
  • Retinitis pigmentosa (RP)
Novel
Name 1
tripartite motif containing 54
Name2
long intergenic non-protein coding RNA 887
Pathway 1
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
caldesmon 1
Name2
SHC adaptor protein 1
Pathway 1
  • Smooth Muscle Contraction
Pathway 2
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • SHC1 events in ERBB2 signaling
  • SHC1 events in ERBB2 signaling
  • SHC1 events in ERBB4 signaling
  • Signalling to RAS
  • Signalling to RAS
  • SHC1 events in EGFR signaling
  • Tie2 Signaling
  • Integrin signaling
  • XBP1(S) activates chaperone genes
  • Interleukin-3, Interleukin-5 and GM-CSF signaling
  • Constitutive Signaling by EGFRvIII
  • RAF/MAP kinase cascade
  • Signal attenuation
  • Insulin receptor signalling cascade
  • Insulin receptor signalling cascade
  • RET signaling
  • Interleukin-15 signaling
  • Interleukin-15 signaling
  • Interleukin-2 signaling
  • Erythropoietin activates RAS
  • Erythropoietin activates RAS
  • Interleukin receptor SHC signaling
  • Constitutive Signaling by Overexpressed ERBB2
  • Signaling by ERBB2 KD Mutants
  • Signaling by ERBB2 ECD mutants
  • Signaling by ERBB2 TMD/JMD mutants
  • Signaling by CSF3 (G-CSF)
  • Signaling by CSF3 (G-CSF)
  • Signaling by CSF1 (M-CSF) in myeloid cells
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
cytochrome b5 type A
Name2
cytochrome P450 family 3 subfamily A member 4
Pathway 1
  • Vitamin C (ascorbate) metabolism
Pathway 2
  • Phase I - Functionalization of compounds
  • Xenobiotics
  • Aflatoxin activation and detoxification
  • Biosynthesis of maresin-like SPMs
  • Aspirin ADME
  • Atorvastatin ADME
  • Prednisone ADME
Drugs 1
  • Dimethyl Propionate Ester Heme
  • Chromium
  • Chromic citrate
  • Chromic nitrate
  • Chromium gluconate
  • Chromium nicotinate
  • Chromous sulfate
Drugs 2
  • Glutathione
  • Isoniazid
  • Pradefovir mesylate
  • Casopitant
  • Cobicistat
  • Diacerein
Diseases 1
  • Methemoglobinemia
Diseases 2
Novel
Name 1
cytochrome b5 type A
Name2
UDP glucuronosyltransferase family 1 member A4
Pathway 1
  • Vitamin C (ascorbate) metabolism
Pathway 2
  • Glucuronidation
  • Heme degradation
  • Defective UGT1A4 causes hyperbilirubinemia
  • Aspirin ADME
Drugs 1
  • Dimethyl Propionate Ester Heme
  • Chromium
  • Chromic citrate
  • Chromic nitrate
  • Chromium gluconate
  • Chromium nicotinate
  • Chromous sulfate
Drugs 2
Diseases 1
  • Methemoglobinemia
Diseases 2
Novel
Name 1
transcription factor CP2
Name2
DnaJ heat shock protein family (Hsp40) member C5 beta
Pathway 1
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
BRCA1 associated protein
Name2
SHC binding and spindle associated 1 like
Pathway 1
  • RAF activation
  • Negative regulation of MAPK pathway
  • Signaling by moderate kinase activity BRAF mutants
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • Signaling downstream of RAS mutants
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
ENY2 transcription and export complex 2 subunit
Name2
ataxin 7 like 3B
Pathway 1
  • HATs acetylate histones
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
NPR3 like, GATOR1 complex subunit
Name2
sestrin 3
Pathway 1
  • Amino acids regulate mTORC1
Pathway 2
  • TP53 Regulates Metabolic Genes
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
nuclear receptor coactivator 5
Pathway 1
Pathway 2
Drugs 1
  • Polyethylene glycol 400
Drugs 2
  • 17alpha-Estriol
Diseases 1
Diseases 2
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
anti-silencing function 1A histone chaperone
Pathway 1
Pathway 2
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
SH3 domain containing GRB2 like, endophilin B1
Pathway 1
Pathway 2
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
mitochondrial elongation factor 1
Pathway 1
Pathway 2
  • Mitochondrial ribosome-associated quality control
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
abhydrolase domain containing 4, N-acyl phospholipase B
Pathway 1
Pathway 2
  • Acyl chain remodelling of PE
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
junctophilin 1
Pathway 1
Pathway 2
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
mitochondrial translational initiation factor 3
Pathway 1
Pathway 2
  • Mitochondrial translation initiation
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
HIV-1 Tat interactive protein 2
Name2
family with sequence similarity 209 member A
Pathway 1
Pathway 2
Drugs 1
  • Polyethylene glycol 400
Drugs 2
Diseases 1
Diseases 2

Page 28 out of 31 pages

© Madhavi K. Ganapathiraju 2012-2025